Valuation: Proteome Sciences plc

Market Cap 4.31M 5.67M 5.17M 4.78M 8.12M 530M 8.44M 57.73M 22.82M 286M 21.27M 20.82M 903M P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 19.3M 25.37M 23.13M 21.39M 36.35M 2.37B 37.79M 258M 102M 1.28B 95.16M 93.17M 4.04B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.48%
Yield 2024 *
-
Yield 2025 -
1 day-14.65%
1 week-18.93%
Current month-27.85%
1 month-27.85%
3 months-41.52%
6 months-28.59%
Current year-58.01%
1 week 1.01
Extreme 1.01
1.61
1 month 1.01
Extreme 1.01
1.7
Current year 1.01
Extreme 1.01
4.4
1 year 1.01
Extreme 1.01
4.4
3 years 1.01
Extreme 1.01
6.3
5 years 1.01
Extreme 1.01
8.79
10 years 1.01
Extreme 1.01
10
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 74 01/08/2017
Director/Board Member 62 01/01/2010
Date Insider Type Main position Quantity % Market Cap. Importance
4/14/23 A
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
4/14/23 A
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
4/6/23 A
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
-14.65%-18.93%-36.18%-81.58% 5.67M
-0.22%-4.40%-19.63%+4.95% 181B
-1.56%-0.88%-0.08%+34.72% 123B
+0.19%-0.20%-11.51%+10.32% 121B
-1.77%-1.25%-42.45%+0.61% 91.11B
-0.64%-0.45%-3.69%+78.62% 66.47B
+0.31%+0.73%+12.35%-7.37% 58.86B
+1.19%-0.59%+4.22%+50.63% 55.03B
+0.38%-2.16%+3.38%+42.16% 48.88B
+0.90%+3.82%+3.44%-0.67% 35.5B
Average -1.49%-1.15%-9.02%+13.24% 78B
Weighted average by Cap. -0.16%-1.13%-10.01%+20.61%

Financials

2024 2025
Net sales 4.89M 6.42M 5.86M 5.42M 9.2M 600M 9.57M 65.4M 25.85M 324M 24.09M 23.59M 1.02B 3.76M 4.94M 4.5M 4.16M 7.07M 461M 7.35M 50.27M 19.87M 249M 18.52M 18.13M 786M
Net income -3.41M -4.48M -4.08M -3.77M -6.41M -418M -6.67M -45.58M -18.02M -226M -16.79M -16.44M -713M -3.06M -4.02M -3.67M -3.39M -5.76M -376M -5.99M -40.96M -16.19M -203M -15.09M -14.77M -641M
Net Debt 13.39M 17.6M 16.05M 14.84M 25.23M 1.64B 26.22M 179M 70.86M 888M 66.03M 64.65M 2.8B 14.99M 19.7M 17.96M 16.61M 28.23M 1.84B 29.34M 201M 79.29M 993M 73.9M 72.35M 3.14B
Projected Income Statement - Annual - Proteome Sciences plc
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
19/11/26 GBX 1.050 -14.65% 1,657
18/11/26 GBX 1.230 -10.87% 3,608
17/11/26 GBX 1.380 -1.43% 499,557
16/11/26 GBX 1.400 +2.94% 96,165
13/11/26 GBX 1.360 +5.02% 6,211